PEPTIDO Y COMPOSICION FARMACEUTICA PARA EL TRATAMIENTO DEL CANCER

The invention relates to peptides comprising the fragment 266-283 of connexin 43 of SEQ ID n° 1, and to the use of said peptides for the treatment of diseases associated with cell proliferation, in particular for the treatment of gliomas. The invention also relates to the pharmaceutical composition(...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GANGOSO RODRÍGUEZ, ESTER, TABERNERO URBIETA, ARANTXA, MEDINA JIMÉNEZ, JOSÉ MARÍA
Format:	Patent
Sprache:	spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to peptides comprising the fragment 266-283 of connexin 43 of SEQ ID n° 1, and to the use of said peptides for the treatment of diseases associated with cell proliferation, in particular for the treatment of gliomas. The invention also relates to the pharmaceutical composition(s) and the kit comprising said peptides.